Abstract
Background
Cystatin C (CysC) is a potent nonorgan-specific cysteine protease inhibitor and may contribute to elastolysis and tissue destruction by a mechanism of protease–antiprotease imbalance. Given the prevalence of CysC in the serum of smokers and its role in tissue destruction, we aimed to evaluate the association between CysC and emphysema.
Methods
Pooled cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 were used. Emphysema and chronic bronchitis were defined by a self-reported history ascertained using standardized questionnaires. Active smokers were defined as self-reported current smokers or measured serum cotinine ≥10 ng/mL. Nonactive smokers with a serum cotinine level >0.05 ng/mL were defined as environmental tobacco smoke (ETS)-exposed.
Results
The prevalence (95% CI) of emphysema was 1.3% (range = 0.9–1.8%). The mean (SE) CysC level in the emphysema group was significantly higher than in normal controls [1,139 (22) vs. 883 (8) μg/L; p = 0.001]. Upon stratification of the study population by C-reactive protein (CRP) concentrations, we demonstrated a progressive increase in the mean serum CysC level with serially increasing CRP concentrations. Active smokers with emphysema had 115.4 (46.5) μg/L higher mean (SE) CysC levels than the normal controls (p < 0.001). Upon adjusted analysis, we observed that nonactive smokers with significant ETS exposure had 31.2 (15.2) μg/L higher mean (SE) serum CysC levels as compared to ETS unexposed nonactive smokers (p = 0.04).
Conclusion
In a large representative noninstitutionalized US population, we demonstrated an association between emphysema and serum CysC. Active smokers with emphysema had significantly higher CysC levels. These findings suggest that CysC may play a role in the pathogenesis of smoking-related emphysema.
References
Jannoff A, Sloan B, Weinbaum G et al (1977) Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 115:461–478
Owen CA, Campbell EJ (1999) The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 65:137–150
Lesser M, Padilla ML, Cardozo C (1992) Induction of emphysema in hamsters by intratracheal instillation of cathepsin B. Am Rev Respir Dis 145:661–668
Chughtai B, O’Riordan TG (2004) Potential role of inhibitors of neutrophil elastase in treating diseases of the airway. J Aerosol Med 17:289–298
Chua F, Laurent GJ (2006) Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 3:424–427
Lungarella G, Cavarra E, Lucattelli M, Martorana PA (2008) The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol 40:1287–1296
Owen CA (2008) Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis 3:253–268
Abboud RT, Vimalanathan S (2008) Pathogenesis of COPD. Part 1. The role of protease–antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 12:361–367
Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis, and therapy in cancer. Oncol Rep 5:1349–1361
Chapman HA, Stone OL (1984) Comparison of live human neutrophils and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J Clin Invest 74:1693–1700
Abbott DE, Margaryan NV, Jeruss JS et al (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9:23–30
Meng L, Yang Y, Qi LT, Wang XJ, Xu GB, Zhang BW (2011) Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol. doi:10.5301/jn.5000020
Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L (2011) Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial 15:261–268
Kottgen A, Selvin E, Stevens LA et al (2008) Serum cystatin C in the United States: the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51:385–394
Kyhse-Andersen J, Schmidt C, Nordin G et al (1994) Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921–1926
Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221–226
Zore I, Krasovec M, Cimerman N et al (2001) Cathepsin B/Cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem 382:805–810
Poteryaeva ON, Falameyeva OV, Korolenko TA et al (2000) Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. Drugs Exp Clin Res 26:301–306
Krepela E, Prochazka J, Karova B, Cermak J, Roubkova H (1998) Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 45:318–331
Kos J, Werle B, Lah T, Brunner N (2000) Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 15:84–89
Werle B, Schanzenbacher U, Lah TT et al (2006) Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. Oncol Rep 16:647–655
Buttle DJ, Burnett D, Abrahamson M (1990) Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. Scand J Clin Lab Invest 50:509–516
Luthgens K, Ebert W, Trefz G, Gabrijelcic D, Turk V, Lah T (1993) Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect Prev 17:387–397
Werle B, Sauckel K, Nathanson CM et al (2003) Cystatins C, E/M, and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 382:281–287
Warfel AH, Cardozo C, Yoo OH, Zucker-Franklin D (1991) Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukoc Biol 49:41–47
Altiok O, Yasumatsu R, Bingol-Karakoc G et al (2006) Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173:318–326
Centers for Disease Control and Prevention (2010) NHANES–National Health and Nutrition Examination Survey homepage. Available at http://www.cdc.gov/nchs/nhanes.htm/. Accessed 3 August 2010
Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification. Ann Intern Med 139:137–147
Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047
Selvin S, Manzi J, Stevens LA et al (2007) Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004. Am J Kidney Dis 50:918–926
Korkmaz B, Horwitz MS, Jenne DE, Gauthier F (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human disease. Pharmacol Rev 62:726–759
Abrahamson M (1994) Cystatins. Methods Enzymol 244:685–700
Salgado JV, Neves FA, Bastos MG et al (2010) Monitoring renal function: measured and estimated glomerular filtration rates—a review. Braz J Med Biol Res 43:528–536
Lafarge JC, Naour N, Clement K, Guerre-Millo M (2010) Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92:1580–1586
Shlipak MG, Marnak MJ, Katz R et al (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049–2060
Finlay GA, Russell KJ, McMahon KJ et al (1997) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52:502–506
Henskens YM, Veerman EC, Amerongen AV (1996) Cystatins in health and diseases. Biol Chem Hoppe Seyler 377:71–86
Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003) Cystatins. Biochem Soc Symp 70:179–199
Finkelstein R, Fraser RS, Ghezzo H, Cosio MG (1995) Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152:1666–1672
Takeyabu K, Betsuyaku T, Nishimura M et al (1998) Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J 12:1033–1039
Chapman HA, Reilly JJ, Yee R, Grubb A (1990) Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis 141:698–705
Sloane BF, Rozhin J, Robinson D, Honn KV (1990) Role for cathepsin B and cystatins in tumor growth and progression. Biol Chem Hoppe Seyler 371:193–198
Woischnik M, Bauer A, Aboutaam R et al (2008) Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J 31:1197–1204
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rokadia, H.K., Agarwal, S. Serum Cystatin C and Emphysema: Results from the National Health and Nutrition Examination Survey (NHANES). Lung 190, 283–290 (2012). https://doi.org/10.1007/s00408-012-9374-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-012-9374-z